Breaking News
Get 40% Off 0
👀 Reveal Warren Buffett's stock picks that are beating the S&P 500 by +174.3% Get 40% Off
Close

Seagen Inc (SGEN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Seagen's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Seagen historical data, for real-time data please try another search
228.74 0.00    0.00%
13/12 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 228.74 - 228.96
Seagen 228.74 0.00 0.00%

SGEN Recent Sentiments

 
This page contains information on users’ sentiments for the Seagen Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jan 23, 2024 שגיא קורולקאר   228.74 Jan 29, 2024 @ 228.74 0.00%
Dec 12, 2023 Manuel Rojas   228.83 Jan 05, 2024 @ 228.74 -0.04%
Dec 12, 2023 Grzegorz Pożarski   222.95 Dec 18, 2023 @ 228.74 +2.60%
Dec 07, 2023 Lara de Jonge   218.44 Dec 29, 2023 @ 228.74 -4.72%
Dec 05, 2023 Yasmina Raupova   213.70 Dec 29, 2023 @ 228.74 +7.04%
Oct 31, 2023 Carl Ren   213.22 Nov 30, 2023 @ 213.52 +0.14%
Oct 18, 2023 Alfredo Navarro   215.37 Nov 30, 2023 @ 213.52 -0.86%
Oct 05, 2023 Daniel Kaiser   213.88 Nov 30, 2023 @ 213.52 +0.17%
Oct 03, 2023 BAU BAQSHA...   212.11 Nov 30, 2023 @ 213.52 -0.66%
Sep 22, 2023 Skylar Mitchell   213.59 Sep 22, 2023 @ 213.63 -0.02%
Aug 24, 2023 samet elmas   197.74 Nov 30, 2023 @ 213.52 +7.98%
Aug 22, 2023 Heera Singh   194.50 Nov 30, 2023 @ 213.52 +9.78%
Aug 09, 2023 Adan Pe   194.81 Nov 30, 2023 @ 213.52 -9.60%
Jun 29, 2023 Gaissadin Nurlukul   192.09 Nov 30, 2023 @ 213.52 +11.16%
Jun 22, 2023 Yasmina Raupova   199.36 Jun 23, 2023 @ 198.91 -0.23%
May 17, 2023 Zevik Power   190.47 Nov 30, 2023 @ 213.52 +12.10%
May 16, 2023 Arman Kala   186.02 Nov 30, 2023 @ 213.52 -14.78%
May 16, 2023 Georg Schneider   187.56 Nov 30, 2023 @ 213.52 +13.84%
Apr 18, 2023 Richard Radloff   205.06 Apr 26, 2023 @ 201.40 +1.78%
Apr 14, 2023 Adan Pe   206.04 May 09, 2023 @ 198.23 +3.79%
Apr 05, 2023 Darlin Ramos   204.80 May 09, 2023 @ 198.23 +3.21%
Apr 05, 2023 Sujata Patra   205.65 Apr 06, 2023 @ 205.98 +0.16%
Apr 03, 2023 Aslan M   201.05 May 09, 2023 @ 198.23 -1.40%
Mar 30, 2023 Javier Santamaria...   203.16 Apr 21, 2023 @ 203.80 -0.32%
Mar 28, 2023 fabio mazzeo   202.93 Apr 21, 2023 @ 203.80 +0.43%
Mar 17, 2023 Nick Andries   200.13 Apr 07, 2023 @ 205.55 +2.71%
Mar 14, 2023 ציון חסון   199.09 Apr 07, 2023 @ 205.55 +3.24%
Mar 14, 2023 Nicola Bommezzadri   198.72 Apr 07, 2023 @ 205.55 +3.44%
Mar 14, 2023 Vijaya Chandra Reddy   198.97 Apr 07, 2023 @ 205.55 +3.31%
Mar 13, 2023 Alexander Drozdov   199.21 Apr 07, 2023 @ 205.55 -3.18%
Mar 13, 2023 Alex Ce   198.82 Apr 07, 2023 @ 205.55 +3.38%
Mar 13, 2023 Manuel Martin Rasco   200.05 Apr 07, 2023 @ 205.55 -2.75%
Mar 13, 2023 Paolo Causarano   201.00 Apr 07, 2023 @ 205.55 +2.26%
Mar 13, 2023 joao mendonca   200.65 Apr 07, 2023 @ 205.55 +2.44%
Mar 13, 2023 Дарья Кузнецова   199.16 Mar 14, 2023 @ 197.65 -0.76%
Mar 08, 2023 Anne Marie Surnson   175.87 Mar 13, 2023 @ 200.83 +14.19%
Mar 06, 2023 Carl Ren   179.04 Mar 31, 2023 @ 202.47 +13.09%
Mar 02, 2023 Przemysław Borowik   177.11 Mar 24, 2023 @ 197.64 -11.59%
Feb 27, 2023 fabio mazzeo   177.87 Mar 24, 2023 @ 197.64 +11.11%
Feb 27, 2023 Jose Antonio Cortes   176.38 Mar 24, 2023 @ 197.64 -12.05%
Feb 27, 2023 Daniele Bertani   181.05 Mar 06, 2023 @ 178.59 -1.36%
Feb 27, 2023 효정 김   180.97 Mar 24, 2023 @ 197.64 +9.21%
Feb 16, 2023 Richard Pujalat   160.41 Feb 20, 2023 @ 162.53 +1.32%
Feb 16, 2023 און טן   159.02 Feb 20, 2023 @ 162.53 -2.21%
Jan 30, 2023 Iurii Syrbu   138.60 Feb 24, 2023 @ 161.37 +16.43%
Jan 09, 2023 Adan Pe   130.13 Feb 03, 2023 @ 138.00 -6.05%
Dec 30, 2022 Владимир Жбанов   126.19 Jan 02, 2023 @ 128.51 +1.84%
Dec 21, 2022 Mario Escamilla   132.82 Dec 21, 2022 @ 132.15 -0.50%
Dec 12, 2022 Amila Dayarathna   129.36 Dec 12, 2022 @ 129.77 +0.32%
Nov 29, 2022 Andrea Perrucchietti   118.16 Dec 05, 2022 @ 122.09 +3.33%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SGEN Comments

Write your thoughts about Seagen Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Muhammad dayala
Muhammad dayala Jun 05, 2023 7:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
its an arbitrage opportunity
Milk Hey
Milk Hey Jul 18, 2022 9:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what happened?
Azeem Haider
Azeem Haider Sep 20, 2021 2:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
azeem Malik
Hakan YILMAZ
Hakan YILMAZ Feb 12, 2021 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The European Commission (EC) has granted marketing authorization for Seagen's (NASDAQ:SGEN) Tukysa (tucatinib) in combination with trastuzumab and capecitabine for the treatment of adult patients with HER2-positive locally advanced or metastatic breast cancer who have received at least two prior anti-HER2 treatment regimens.
Prabhu PR
PrabhuJ Feb 05, 2021 7:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is the news?
Ludovic Raymond
Ludovic Raymond Feb 05, 2021 7:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Apprently they may be included in the S&P 500, and hence funds. Just like Tesla a few weeks back
Hakan YILMAZ
Hakan YILMAZ Feb 05, 2021 7:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ludovic Raymond  Did you hold a position?
Hakan YILMAZ
Hakan YILMAZ Feb 01, 2021 11:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Seagen to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021
Charles Coolidge
Charles Coolidge Jan 06, 2021 12:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Price drop is the result of the #1 Institutional holder (Baker Bros) selling the entire position.
Hakan YILMAZ
Hakan YILMAZ Jan 06, 2021 12:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You say Baker Bros sold the entire position, 27.5%. this is not possible. not that much volume.
Charles Coolidge
Charles Coolidge Jan 06, 2021 12:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Executing through a secondary offering. The company issued a press release on it.
Mike Cronin
Mike Cronin Jan 06, 2021 12:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Charles Coolidge, prove it.
Mike Cronin
Mike Cronin Jan 06, 2021 12:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Charles Coolidge, prove it.
Hakan YILMAZ
Hakan YILMAZ Dec 17, 2020 4:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Seagen (SGEN) Gets Positive CHMP Opinion for Breast Cancer Drug  December 14, 2020
Nick Neri
Nick Neri Nov 30, 2020 4:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
180+
Nick Neri
Nick Neri Nov 13, 2020 4:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy buy buy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email